本文選題：舒芬太尼　切入點(diǎn)：嗎啡　出處：《重慶醫(yī)科大學(xué)》2014年碩士論文　論文類(lèi)型：學(xué)位論文

【摘要】：目的：本研究旨在比較不同劑量舒芬太尼和嗎啡對(duì)先天性心臟病手術(shù)后鎮(zhèn)痛的臨床效果及不良反應(yīng)，為舒芬太尼廣泛用于幼兒術(shù)后鎮(zhèn)痛提供合適的用藥依據(jù)。 方法：前瞻性研究，選取重慶醫(yī)科大學(xué)附屬兒童醫(yī)院心胸外科2011年11月至2012年3月期間在體外循環(huán)+全身麻醉下完成的ASAI-II級(jí)120例先天性心臟病手術(shù)患者，采用單盲方法隨機(jī)分為4組，舒芬太尼1組（S1），舒芬太尼2組（S2），舒芬太尼3組（S3），嗎啡組（M），每組30例。術(shù)后入重癥監(jiān)護(hù)室連接鎮(zhèn)痛泵開(kāi)始持續(xù)鎮(zhèn)痛，S1組給予舒芬太尼維持劑量0.03g·kg-1·h-1+咪達(dá)唑倫2g·kg-1·min-1；S2組給予舒芬太尼維持劑量0.04g·kg-1·h-1+咪達(dá)唑倫2g·kg-1·min-1；S3組給予舒芬太尼維持劑量0.05g·kg-1·h-1+咪達(dá)唑倫2g·kg-1·min-1；M組給予嗎啡維持劑量15g·kg-1·h-1+咪達(dá)唑倫2g-1·kg-1·min-1。于術(shù)后1，4，8，12，24h進(jìn)行面部表情疼痛評(píng)分、Ramsay鎮(zhèn)靜評(píng)分，持續(xù)監(jiān)測(cè)心率(heartrate,HR)、平均動(dòng)脈壓(mean arterial pressure,MAP)、血糖(bloodsuger,BS)、血乳酸(lactate concentration,Lac)、血清皮質(zhì)醇(cortisol,Cor)的含量，并對(duì)各組出現(xiàn)惡心、嘔吐、皮疹的不良反應(yīng)次數(shù)及臨時(shí)追加咪達(dá)唑侖鎮(zhèn)靜藥物的次數(shù)進(jìn)行觀察和比較。統(tǒng)計(jì)學(xué)處理：計(jì)量資料以均數(shù)±標(biāo)準(zhǔn)差表示，組間計(jì)量資料比較采用單因素方差分析，計(jì)數(shù)資料采用卡方檢驗(yàn)，P＜0.05為差異有統(tǒng)計(jì)學(xué)意義。采用GraphPad Prism5程序繪制圖表并比較。 結(jié)果：與M組相比，S1、S2、S3組在術(shù)后1h鎮(zhèn)痛、鎮(zhèn)靜滿(mǎn)意度顯著升高，其余各時(shí)點(diǎn)4組無(wú)明顯差異；M組需臨時(shí)追加鎮(zhèn)靜藥物人次明顯增多；4組患兒在術(shù)后1h及4h血清皮質(zhì)醇水平均顯著高于正常生理水平（p＜0.05），M組在術(shù)后1h點(diǎn)血清皮質(zhì)醇較其余3組明顯增高；4組間HR、RR、MAP、BS、Lac及術(shù)后不良反應(yīng)均無(wú)明顯差異。 結(jié)論：舒芬太尼用于先天性心臟病術(shù)后患兒鎮(zhèn)痛效果優(yōu)于嗎啡，舒芬太尼0.03g·kg-1·h-1至0.05g·kg-1·h-1劑量范圍復(fù)合咪達(dá)唑侖2g·kg-1·min-1均能達(dá)到滿(mǎn)意鎮(zhèn)痛效果。舒芬太尼0.05g·kg-1·h-1復(fù)合咪達(dá)唑侖2g·kg-1·min-1不良反應(yīng)少，需臨時(shí)需追加鎮(zhèn)靜藥物少，為小兒術(shù)后鎮(zhèn)靜的安全理想藥物組合。
[Abstract]:Objective: to compare the clinical effects and adverse reactions of different doses of sufentanil and morphine on postoperative analgesia of congenital heart disease. Methods: a prospective study was conducted on 120 patients with ASAI-II grade congenital heart disease who underwent cardiothoracic surgery under general anesthesia under cardiopulmonary bypass from November 2011 to March 2012 in the Children's Hospital affiliated to Chongqing Medical University. A single blind method was used to divide into 4 groups at random. Sufentanil, sufentanil, sufentanil, sufentanil, sufentanil, sufentanil, and morphine, 30 patients in each group, respectively. The group S 1 was given sufentanil at a maintenance dose of 0.03 g 路kg-1 路h -1 midazolone 2 g 路kg-1 路min -1 after operation. The maintenance dose of sufentanil was 0.04g 路kg-1 路h-1 midazolam 2g 路kg-1 路min-1C S3. The maintenance dose of sufentanil was 0.05g 路kg-1 路h-1 midazolone 2g 路kg-1 路min-1. The morphine maintenance dose was 15g 路kg-1 路h-1 midazolam 2g-1 路kg-1 路min-1. Continuous monitoring of heart rate and heart rate, mean arterial pressure, mean arterial pressure MAPP, blood sugar and blood sugersBSU, lactate lactate concentration, serum cortisol, and nausea and vomiting in each group. The number of adverse reactions of skin rash and the times of temporary addition of midazolam sedation were observed and compared. Statistical analysis: the metrological data were expressed as mean 鹵standard deviation, and the measurement data were compared by single factor ANOVA. There was significant difference in counting data by chi-square test (P < 0. 05). The chart was drawn by GraphPad Prism5 program and compared. Results: compared with M group, the analgesia and sedation satisfaction were significantly increased in group S _ 1 and S _ 2 + S _ 3 at 1 h after operation. There was no significant difference among the other four groups at other time points. The need for temporary sedation in group M was significantly increased. The serum cortisol levels in group 4 were significantly higher than those in normal physiological level at 1 h and 4 h after operation, p < 0. 05 and P < 0. 05 respectively. At 1 h after operation, the levels of serum cortisol in group M were significantly higher than those in group 1. There was no significant difference between the other three groups in HRN RRN MAPP BSU Lac and postoperative adverse reactions. Conclusion: the analgesic effect of sufentanil in postoperative children with congenital heart disease is better than that of morphine. The analgesic effect of sufentanil 0.03g 路kg-1 路h-1 to 0.05g 路kg-1 路h-1 combined with midazolam 2g 路kg-1 路min-1 can achieve satisfactory analgesic effect, sufentanil 0.05g 路kg-1 路h-1 combined with midazolam 2g 路kg-1 路min-1 has less adverse reactions. It is a safe and ideal combination of sedation for pediatric postoperative sedation.
【學(xué)位授予單位】：重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2014
【分類(lèi)號(hào)】：R614

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 徐露;李元海;;舒芬太尼的藥理作用和臨床應(yīng)用研究進(jìn)展[J];安徽醫(yī)藥;2011年03期

2 吳菊霜;;鎮(zhèn)痛鎮(zhèn)靜治療對(duì)ICU患者不適體驗(yàn)的影響[J];福建醫(yī)藥雜志;2011年04期

3 宋國(guó)維;小兒危重病例評(píng)分[J];中華急診醫(yī)學(xué)雜志;2003年05期

4 方欣;張建敏;;小兒術(shù)后鎮(zhèn)痛治療[J];臨床藥物治療雜志;2013年01期

5 陳們螈;劉斌;;先天性心臟病診斷及治療進(jìn)展[J];西南軍醫(yī);2012年03期

6 蘇肇伉;先天性心臟病外科進(jìn)展[J];上海第二醫(yī)科大學(xué)學(xué)報(bào);2004年03期

7 王建光;連慶泉;張冰;;小兒疼痛的評(píng)估[J];實(shí)用兒科臨床雜志;2006年11期

8 遲巖;徐詠梅;;芬太尼誘發(fā)嗆咳反應(yīng)的治療進(jìn)展[J];實(shí)用醫(yī)學(xué)雜志;2012年14期

9 田明清,高崇榮;關(guān)于完善疼痛定義的探討[J];中國(guó)臨床康復(fù);2003年04期

10 許峰;;疼痛,一個(gè)尚未引起兒科醫(yī)師足夠重視的問(wèn)題[J];中華兒科雜志;2005年12期

，

本文編號(hào)：1630271